Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Parkinson Disease 4, Autosomal Dominant Lewy Body × Dacarbazine × 1 year × Clear all

Sponsor

Conditions

Hodgkin Disease 16 Melanoma 6 Sarcoma 3 Neoplasms 2 Lymphoma 2 Leiomyosarcoma 2 Uveal Melanoma 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Lung Neoplasms 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Kidney Neoplasms 1 Immunotherapy 1 Hyperthermia 1 Colonic Neoplasms 1 Breast Neoplasms 1 Advanced Melanoma 1

Interventions

pembrolizumab 104 Cisplatin 28 lenvatinib 26 Paclitaxel 24 Carboplatin 24 Pemetrexed 13 Gemcitabine 9 Docetaxel 9 Saline Solution 8 Fluorouracil 8 Capecitabine 7 olaparib 6 Oxaliplatin 6 Bevacizumab 6 Albumin-Bound Paclitaxel 6 epacadostat 5 Etoposide 5 Cetuximab 5 belzutifan 4 Leucovorin 4 130-nm albumin-bound paclitaxel 4 patritumab deruxtecan 3 enzalutamide 3 durvalumab 3 Glucose 3 Dexamethasone 3 Acetaminophen 3 trifluridine tipiracil drug combination 2 regorafenib 2 liposomal doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡